Long-term adjuvant treatment of primary intermediate to high-risk malignant melanoma [abstract]
Arzneim.Forsch/Drug ResAugustin, Matthias; Bock, Paul R.; Hanish, Jürgen; Karasmann, Marita; Schneider, Bertholdmelanoma, efficacy, survival, comparative cohort study, Safety, Mistletoe